Document Detail

Immediate versus delayed self-reporting of symptoms and side effects during chemotherapy: Does timing matter?
MedLine Citation:
PMID:  20685164     Owner:  NLM     Status:  In-Data-Review    
PURPOSE: The aim of this study was to examine how patients recall symptoms at a delayed self-report. Accurate insight into toxicity symptoms during chemotherapy is essential so that nurses and doctors can assess therapeutic tolerance and adjust supportive care accordingly.
METHOD: A non-experimental, longitudinal design was employed. Using the Therapy-Related Symptoms Checklist (TRSC), respondents (n = 142) reported their initial symptoms during the first 7 days of the chemotherapy cycle at two different times: (1) each day of the first seven days after the chemotherapy administration (immediate self-report), and (2) at their next hospital visit for chemotherapy (delayed self-report). We compared the number and severity of symptoms and side effects reported in the immediate and delayed self-reports.
RESULTS: Respondents reported significantly fewer symptoms and fewer severe symptoms in the delayed self-report. For 22 out of 25 symptoms the delayed-reported grade was significantly lower than the immediate-reported maximum grade. Compared to the immediate-reported median grade, significant differences occurred in only 10 out of the 25 symptoms. In all cases, except fatigue, the delayed-reported grade was significantly higher than the immediate-reported median grade.
CONCLUSIONS: This study indicates that delayed self-report of chemotherapy side effects is not an appropriate measure of actual symptoms and side effects experienced by patients. Delayed self-report gives a weaker insight into actual symptom burden. Fatigue is at particular risk to be minimized at the delayed self-report. Therefore it is recommended to assess chemotherapy-related symptoms and side effects by means of immediate self-report.
Annemarie Coolbrandt; Koen Van den Heede; Ellen Vanhove; Ann De Bom; Koen Milisen; Hans Wildiers
Related Documents :
1451314 - Acute achilles tendonitis following oral isotretinoin therapy for acne vulgaris.
822394 - Anticoagulants for avian and reptilian blood: heparin and edta.
23955424 - Markers for nutrition studies: review of criteria for the evaluation of markers.
24651364 - Regenerative endodontics.
7435284 - Schwannomas of the orbit.
16933314 - Rare living hypopharyngeal foreign body.
Publication Detail:
Type:  Journal Article     Date:  2010-08-03
Journal Detail:
Title:  European journal of oncology nursing : the official journal of European Oncology Nursing Society     Volume:  15     ISSN:  1532-2122     ISO Abbreviation:  Eur J Oncol Nurs     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-03-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100885136     Medline TA:  Eur J Oncol Nurs     Country:  Scotland    
Other Details:
Languages:  eng     Pagination:  130-6     Citation Subset:  IM; N    
Copyright Information:
Copyright © 2010 Elsevier Ltd. All rights reserved.
Department of Oncology/Hematology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence.
Next Document:  Therapeutic applications of ribozymes and riboswitches.